FDA Inspection 1190669 — Bloodworks
The FDA completed an inspection of Bloodworks on November 9, 2022 in Renton, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 9, 2022
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Renton, WA (United States)